ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000213963.2	Ponatinib	Bladder urothelial carcinoma	0.038318079	Resistant
ENSG00000213963.2	Ponatinib	Breast invasive carcinoma	0.029532331	Sensitive